Innovent Biologics | Sustainability & Chart

KYG4818G1010

Basic information on Innovent Biologics

Location: Cayman Islands

Industry: Health Services

Website

Impact Score

Description Innovent Biologics

Innovent Biologics Inc. is a Chinese biopharmaceutical company engaged in the research, development, manufacturing, and commercialization of biologic medicines for diseases including oncology, immunology, and others.

Innovent Biologics Sustainability Performance

Climate

20%

Renewable Energy

No data available for Innovent Biologics. Target value per method: min. 100%

Greenhouse Gas Emissions

Innovent Biologics emits 2,3 times its CO₂ budget of 36,462 tons of CO₂ equivalent. Target value per method: max. 100% of CO₂ budget

Supply Chain

Taking into account the entire supply chain, Innovent Biologics emits 2,8 times its CO₂ budget of 36,462 tons of CO₂ equivalent. Target value per method: max. 100% of CO₂ budget

Recycling and Recovery of Waste

No data available for Innovent Biologics. Target value per method: min. 75%

Society

44%

Union Formation and Collective Bargaining Power

No data available for Innovent Biologics. Target value per method: min. 80%

CEO Pay Ratio

No data available for Innovent Biologics. Target value per method: max. 20-30 times

Employee Turnover Rate

Innovent Biologics has an employee turnover rate of 13,3%. Target value per method: max. 10%

Harassment and Discrimination at the Workplace

Innovent Biologics meets 4 quality criteria for handling harassment and discrimination at the workplace. Target value per method: 4 quality criteria

Gender

64%

Women on Board

Innovent Biologics has 22,2% women across its top leadership and supervisory bodies. Target value per method: min. 40%

Gender Pay Gap

No data available for Innovent Biologics. Target value per method: max. 3%

Women in Management

Innovent Biologics employs 45,2% female managers. Target value per method: min. 40%

Glass Ceiling

The proportion of women in senior management at Innovent Biologics is 88,7% of the proportion of women in the overall workforce. Target value per method: min. 90%

Sustainable [100]

Almost sustainable [67-99]

Moderate [34-66]

Not sustainable [0-33]

No data

Renewable Energy

Greenhouse Gas Emissions

Supply Chain

Waste Recycling

Sustainable [100]

Almost sustainable [67-99]

Moderate [34-66]

Not sustainable [0-33]

No data

We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.

Compare Innovent Biologics with ...

Innovent Biologics

?

Impact Score

Climate

Society

Gender

20%

44%

64%

Innovent Biologics

?

Impact Score

Climate

Society

Gender

Sources of sustainability performance

Metric	Value	Unit	Year	PDF Name	PDF Page
Employee Turnover Rate
Employee turnover	13,3	%	2025	2025ESGEN.pdf	108
Glass Ceiling
Number of employees	7 502	people	2025	2025ESGEN.pdf	89
Women in management	45,2	%	2025	2025ESGEN.pdf	87
Women in workforce	3 825	Male	2025	2025ESGEN.pdf	173
Greenhouse Gas Emissions
Scope 2 emissions, location based	74 685,26	Tons of carbon dioxide equivalent	2025	2025ESGEN.pdf	171
Number of employees	7 502	people	2025	2025ESGEN.pdf	89
Scope 1 emissions	7 802,76	Tons of carbon dioxide equivalent	2025	2025ESGEN.pdf	171
Harassment and Discrimination at the Workplace
Incident notification mechanism	Yes		2025	2025ESGEN.pdf	107
Anti-discrimination policy	Yes		2025	2025ESGEN.pdf	146
Retaliation safeguards	Yes		2025	2025ESGEN.pdf	25
Confidentiality mechanisms	Yes		2025	Innovent_Biologics_Code_of_Ethics_and_Business_Conduct.pdf	5
Supply Chain
Scope 2 emissions, location based	74 685,26	Tons of carbon dioxide equivalent	2025	2025ESGEN.pdf	171
Number of employees	7 502	people	2025	2025ESGEN.pdf	89
Scope 3 emissions	19 460,43	Tons	2025	2025ESGEN.pdf	171
Scope 1 emissions	7 802,76	Tons of carbon dioxide equivalent	2025	2025ESGEN.pdf	171
Women on Board
Supervisory board size	9	people	2025	2025ESGEN.pdf	17
Women on supervisory board	2	female	2025	2025ESGEN.pdf	17
Women in Management
Women in management	45,2	%	2025	2025ESGEN.pdf	87

Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.

Find more sustainable companies

Home Find Companies & ETFs Our Method

Imprint Privacy Policy GTCContact UsESG Rating Disclosure

© 2026 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support! Reference data includes information from ESMA FIRDS that has been transformed and enriched by money:care. The use of this reference data does not constitute endorsement of or support for money:care or its products by ESMA. Fund information is based in part on publications by the respective providers and has been processed by money:care. Logos provided by Logo.dev